MOCH KENNETH I sold 0.2% of their position (115.00 shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $40.03 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2023ACC: 0001062993-23-013667
Director
Since Jul 2018
+119.44K
Net shares
Net buyer
$40.03
Total sold
1
Open market trades
0B · 1S
3
Total transactions
119.56K acquired · 115.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+47.82K
Price / share
—
Trade value
—
% of position
170.4%
6/13/2023
28.07K→75.89K
Common Stock
Direct
Shares
−115.00
Price / share
$0.35
Trade value
$40.03
% of position
0.2%
6/14/2023
75.89K→75.78K
Total
Net shares
+47.71K
Net value
-$40.03
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2023 | A · Award | +47.82K | — | — | 170.4% | 28.07K | 75.89K |
| Common Stock Direct | 6/14/2023 | S · Sale | −115.00 | $0.35 | $40.03 | 0.2% | 75.89K | 75.78K |
| Total | +47.71K | -$40.03 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
71.74K shares
Shares
+71.74K
Strike price
0.3501
Held after
71.74K
Exercisable
—
6/13/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock71.74K shares | 6/13/2023 | A · Award | +71.74K | 0.3501 | — | 71.74K |